![George Fromm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
George Fromm is the founder of Kayak Therapeutics, Inc. Senior Director-Research & Development at Scorpius Holdings, Inc. from 2014 to 2017.
Co-Chief Scientific Officer at Shattuck Labs, Inc. from 2023 to 2025.
Education includes graduate and doctorate degrees from Rochester Christian University.
Postes actifs de George Fromm
| Sociétés | Poste | Début |
|---|
Anciens postes connus de George Fromm
| Sociétés | Poste | Fin |
|---|---|---|
| SHATTUCK LABS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2025 |
| SCORPIUS HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2017 |
Formation de George Fromm
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scorpius Holdings, Inc.
 Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Choisissez Zonebourse 
